Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 47 for “"CYP2A6"”.

  1. Establishing Metronidazole as a Novel Biomarker of CYP2A6 Activity

    CYP2A6 is a polymorphically expressed enzyme with variation associated with smoking behavior, cessation success, lung cancer risk, and differential drug exposure to numerous medications including anti-infectious and chemotherapeutic agents. Current CYP2A6 probes that could provide insight a priori …

    umkc Repository record for Establishing Metronidazole as a Novel Biomarker of CYP2A6 Activity (opens in a new tab)

  2. CYP2A6 and CYP2B6: Sources of Variation and their Role in Nicotine Metabolism

    … in a reaction predominantly catalyzed by CYP2A6 (80-90%), with a minor possible role for CYP2B6. Substantial interindividual variability is observed in the rate of nicotine’s inactivation to cotinine and this variation contributes to differences in smoking behaviors (e.g. cigarette …

    toronto-retro Repository record for CYP2A6 and CYP2B6: Sources of Variation and their Role in Nicotine Metabolism (opens in a new tab)

  3. Impact of CYP2A6 Genetic Variation on Nicotine Metabolism and Smoking Behaviours in Light Smoking Populations of Black-African Descent

    … compared to Caucasians. Cytochrome P450 2A6 (CYP2A6) is the main enzyme involved in the metabolism of nicotine and its proximal metabolite cotinine, as well as tobacco-specific nitrosamines. Genetic polymorphisms in CYP2A6 contribute to the large variability observed in rates of nicotine …

    toronto-retro Repository record for Impact of CYP2A6 Genetic Variation on Nicotine Metabolism and Smoking Behaviours in Light Smoking Populations of Black-African Descent (opens in a new tab)

  4. Characterizing Genotyping Methods for CYP2A6, Their Impacts on Prediction of Nicotine Metabolism, and Applications for the Discovery of Novel Associations

    … worldwide, with cessation difficult to achieve. CYP2A6 isthe principal nicotine-inactivating enzyme. Genetic variation in CYP2A6 is associated with altered smoking behaviours, response to smoking cessation pharmacotherapies and risk for tobacco related diseases. The potential for more effective …

    toronto-retro Repository record for Characterizing Genotyping Methods for CYP2A6, Their Impacts on Prediction of Nicotine Metabolism, and Applications for the Discovery of Novel Associations (opens in a new tab)

  5. Variation in Smoking and Nicotine Metabolism Among American Indians: Novel Influences on In Vivo and In Vitro Nicotine Metabolism Phenotypes

    … in the rate of nicotine metabolism (i.e. CYP2A6 activity) has been associated with differences in smoking behaviours and lung cancer risk in other ethnic/racial groups, we then evaluated variation in the CYP2A6 gene and the rate of nicotine metabolism in the Northern Plains and Southwest …

    toronto-retro Repository record for Variation in Smoking and Nicotine Metabolism Among American Indians: Novel Influences on In Vivo and In Vitro Nicotine Metabolism Phenotypes (opens in a new tab)

  6. Big Data Genomic Approaches for Understanding Nicotine Metabolism and Associated Phenotypes

    CYP2A6, a genetically variable enzyme, is crucial in nicotine metabolism, affecting smoking behaviours and health outcomes. CYP2A6 activity can be measured phenotypically (i.e., the nicotine metabolite ratio, NMR) or genomically (i.e., a weighted genetic risk score, wGRS). The first aim was to …

    toronto-retro Repository record for Big Data Genomic Approaches for Understanding Nicotine Metabolism and Associated Phenotypes (opens in a new tab)

  7. The Interaction Between Genetics and Tobacco Consumption in Light Smokers

    … smoking related studies. Genetic variants in CYP2A6, encoding for the major nicotine-metabolizing enzyme, and CHRNA5-A3-B4, encoding for alpha5, alpha3, and beta4 nicotinic receptors, are associated with altered tobacco consumption in heavy smokers, yet little is known about the influence of …

    toronto-retro Repository record for The Interaction Between Genetics and Tobacco Consumption in Light Smokers (opens in a new tab)

  8. THE IMPACT OF DRUG-NICOTINE INTERACTIONS ON SMOKING-RELATED OUTCOMES

    … smoker. Nicotine is primarily metabolized by the CYP2A6 liver enzyme. Medications that interact with nicotine by altering CYP2A6 activity may change how nicotine is metabolized and thus subsequent smoking outcomes. In this dissertation we study the effects of two CYP2A6 medications, namely …

    penn Repository record for THE IMPACT OF DRUG-NICOTINE INTERACTIONS ON SMOKING-RELATED OUTCOMES (opens in a new tab)

  9. Identifying Sources of Missing Heritability and Translating Genomic Variation in Nicotine Metabolism

    … inactivation is mediated predominately by CYP2A6 enzyme activity, phenotyped by the nicotine metabolite ratio (NMR). The NMR is associated with several smoking behaviours, including differences in cessation outcomes and disease risk. The NMR is limited in that it requires specialized assays …

    toronto-retro Repository record for Identifying Sources of Missing Heritability and Translating Genomic Variation in Nicotine Metabolism (opens in a new tab)

  10. The human cytochrome P450 2A family: Comparisons and identification of amino acids essential for substrate recognition

    … has a much higher rate of metabolism than CYP2A6 for both compounds. Combined with its increased affinity and expression in the respiratory tract, CYP2A13 is a candidate for breakdown of NNK into the reactive metabolites that can form DNA adducts in the lung, leading to the development of …

    ku Repository record for The human cytochrome P450 2A family: Comparisons and identification of amino acids essential for substrate recognition (opens in a new tab)

  11. Role of cytochrome P450 enzymes on alcohol/nicotine-mediated oxidative stress and cytotoxicity in monocytes/astrocytes: Implications for HIV-infected alcohol/tobacco users

    … In addition, nicotine-metabolizing enzyme CYP2A6 and a major drug-metabolizing enzyme CYP3A4 are induced by alcohol, suggesting their role in unexpected alcohol-drug-tobacco interactions. Our central hypothesis is that CYP2A6, CYP2E1, and CYP3A4 play important role in alcohol, nicotine, and …

    umkc Repository record for Role of cytochrome P450 enzymes on alcohol/nicotine-mediated oxidative stress and cytotoxicity in monocytes/astrocytes: Implications for HIV-infected alcohol/tobacco users (opens in a new tab)

  12. The Effects of Ethanol and Nicotine on Hepatic and Brain CYP2 Family Enzymes in African Green Monkeys

    … and/or brain levels of CYP2E1, CYP2B6 and CYP2A6 in African green monkeys. Monkeys were randomized into four groups (N = 10/group): an ethanol-only group, a nicotine-only group, an ethanol + nicotine group and a control (no drug) group. Ethanol (10% ethanol in sucrose solution) was …

    toronto-retro Repository record for The Effects of Ethanol and Nicotine on Hepatic and Brain CYP2 Family Enzymes in African Green Monkeys (opens in a new tab)

  13. An Investigation of Nicotine Metabolism in Mice: The Impact of Pharmacological Inhibition and Genetic Influences on Nicotine Pharmacology

    … can be used to examine the effects of potential CYP2A6 inhibitors on nicotine metabolism and nicotine-mediated behaviours. Pharmacogenetic studies have demonstrated that in humans, smoking behaviour is associated with rates of nicotine metabolism by the CYP2A6 enzyme. Mouse CYP2A5 shares …

    toronto-retro Repository record for An Investigation of Nicotine Metabolism in Mice: The Impact of Pharmacological Inhibition and Genetic Influences on Nicotine Pharmacology (opens in a new tab)

  14. Sources of Variation in Nicotine Metabolism and Associations with Smoking Abstinence in Adolescents and Adults

    … enzyme, cytochrome P450 2A6 (CYP2A6) changes nicotine clearance and is associated with altered smoking behaviours, including cessation, in adults. We demonstrate here that slow (versus normal) nicotine metabolizers are more likely to achieve prolonged abstinence in adolescence, …

    toronto-retro Repository record for Sources of Variation in Nicotine Metabolism and Associations with Smoking Abstinence in Adolescents and Adults (opens in a new tab)

  15. Refining Associations between Targeted Genes and the Development of Substance Use Disorders

    … the nicotine metabolizing cytochrome P450 gene CYP2A6. Previous studies show slow metabolizers smoke fewer cigarettes, but provide conflicting results on the role of CYP2A6 in nicotine dependence. Using a COGA young adult sample, I found that CYP2A6 metabolism was not associated with smoking …

    wustl Repository record for Refining Associations between Targeted Genes and the Development of Substance Use Disorders (opens in a new tab)

  16. Structure and function of human cytochromes P450 enzymes: Xenobiotic metabolism by CYP2A and steroid biosynthesis by CYP17A1

    … 94% sequence identity with the human hepatic CYP2A6. Despite this very high sequence identity, CYP2A6 metabolizes the procarcinogen NNK at much lower levels. The similarities and differences between these two human CYP2A enzymes with the substrate nicotine and the inhibitor pilocarpine were …

    ku Repository record for Structure and function of human cytochromes P450 enzymes: Xenobiotic metabolism by CYP2A and steroid biosynthesis by CYP17A1 (opens in a new tab)

  17. The effect of Ginkgo Biloba extract on valproic acid metabolism by human liver microsomes from donors with the CYP2C9*1/*1 genotype

    … M with monoclonal antibodies against CYP2B6 and CYP2A6 reduced their formation by a smaller amount, suggesting that they are minor isoforms involved in their formation. Pre-incubation of H LM with monoclonal antibodies against CYP2B6 and CYP2A6 followed by incubation with VPA and GBE dramatically …

    ubc Repository record for The effect of Ginkgo Biloba extract on valproic acid metabolism by human liver microsomes from donors with the CYP2C9*1/*1 genotype (opens in a new tab) Download PDF for The effect of Ginkgo Biloba extract on valproic acid metabolism by human liver microsomes from donors with the CYP2C9*1/*1 genotype (opens in a new tab)

  18. Διερεύνηση της επίδρασης παραγόντων ειδικών του φύλου στην in vivo δραστικότητα του μεταβολικού ενζύμου CYP1A2

    … in the in vivo activity of the enzymes CYP1A2, CYP2A6, XO and NAT-2. Moreover, the distribution of the two most common single nucleotide polymorphisms of CYP1A2 gene (CYP1A2*1C and CYP1A2*1F) was studied in order to investigate the effect of genotype on the phenotypic expression of …

    greece Repository record for Διερεύνηση της επίδρασης παραγόντων ειδικών του φύλου στην in vivo δραστικότητα του μεταβολικού ενζύμου CYP1A2 (opens in a new tab)

  19. Cytochromes P450: Inhibition of CYP2A Enzymes Involved in Xenobiotic Metabolism and Generation of CYP26 Enzymes Involved in Retinoic Acid Metabolism

    … enzymes of the human CYP2A family include CYP2A6 and CYP2A13. CYP2A6 is primarily a hepatic enzyme, while CYP2A13 is mainly expressed within the respiratory tract. Though these two enzymes are primarily localized to different tissues within the body, they share many substrates in common as …

    ku Repository record for Cytochromes P450: Inhibition of CYP2A Enzymes Involved in Xenobiotic Metabolism and Generation of CYP26 Enzymes Involved in Retinoic Acid Metabolism (opens in a new tab)

Page 1 of 3